| Milliam L Kataoka, MD | |
|
30 Locust St, Northampton, MA 01060-2052 | |
| (413) 529-9300 | |
| Not Available |
| Full Name | Milliam L Kataoka |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 33 Years |
| Location | 30 Locust St, Northampton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295976504 | NPI | - | NPPES |
| 110096843A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085B0100X | Radiology - Body Imaging | 231317 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cd Practice Associates Inc | 2567359839 | 304 |
| Riverbend Medical Group Inc | 5698064343 | 159 |
News Archive
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer.
Roche announced today that its innovative dual-target HIV-1 test has received CE Mark certification, allowing it to be sold for clinical use in the European Union. The COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 utilizes a unique design to simultaneously amplify and detect two separate regions of the HIV-1 genome.
Autism spectrum disorders affect nearly 1 in 88 children, with symptoms ranging from mild personality traits to severe intellectual disability and seizures. Understanding the altered genetic pathways is critical for diagnosis and treatment.
More than half of air travellers find that their oxygen saturation drops to a level at which many hospital patients would be prescribed extra oxygen, according to a paper in the May issue of Anaesthesia.
› Verified 8 days ago
| Entity Name | Cd Practice Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295787919 PECOS PAC ID: 2567359839 Enrollment ID: O20040302000290 |
News Archive
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer.
Roche announced today that its innovative dual-target HIV-1 test has received CE Mark certification, allowing it to be sold for clinical use in the European Union. The COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 utilizes a unique design to simultaneously amplify and detect two separate regions of the HIV-1 genome.
Autism spectrum disorders affect nearly 1 in 88 children, with symptoms ranging from mild personality traits to severe intellectual disability and seizures. Understanding the altered genetic pathways is critical for diagnosis and treatment.
More than half of air travellers find that their oxygen saturation drops to a level at which many hospital patients would be prescribed extra oxygen, according to a paper in the May issue of Anaesthesia.
› Verified 8 days ago
| Entity Name | Cooley Dickinson Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477596310 PECOS PAC ID: 8123090560 Enrollment ID: O20040806001098 |
News Archive
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer.
Roche announced today that its innovative dual-target HIV-1 test has received CE Mark certification, allowing it to be sold for clinical use in the European Union. The COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 utilizes a unique design to simultaneously amplify and detect two separate regions of the HIV-1 genome.
Autism spectrum disorders affect nearly 1 in 88 children, with symptoms ranging from mild personality traits to severe intellectual disability and seizures. Understanding the altered genetic pathways is critical for diagnosis and treatment.
More than half of air travellers find that their oxygen saturation drops to a level at which many hospital patients would be prescribed extra oxygen, according to a paper in the May issue of Anaesthesia.
› Verified 8 days ago
| Entity Name | Riverbend Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841651197 PECOS PAC ID: 5698064343 Enrollment ID: O20160614001710 |
News Archive
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer.
Roche announced today that its innovative dual-target HIV-1 test has received CE Mark certification, allowing it to be sold for clinical use in the European Union. The COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 utilizes a unique design to simultaneously amplify and detect two separate regions of the HIV-1 genome.
Autism spectrum disorders affect nearly 1 in 88 children, with symptoms ranging from mild personality traits to severe intellectual disability and seizures. Understanding the altered genetic pathways is critical for diagnosis and treatment.
More than half of air travellers find that their oxygen saturation drops to a level at which many hospital patients would be prescribed extra oxygen, according to a paper in the May issue of Anaesthesia.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Milliam L Kataoka, MD 30 Locust St, Northampton, MA 01060-2052 Ph: (413) 529-9300 | Milliam L Kataoka, MD 30 Locust St, Northampton, MA 01060-2052 Ph: (413) 529-9300 |
News Archive
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer.
Roche announced today that its innovative dual-target HIV-1 test has received CE Mark certification, allowing it to be sold for clinical use in the European Union. The COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 utilizes a unique design to simultaneously amplify and detect two separate regions of the HIV-1 genome.
Autism spectrum disorders affect nearly 1 in 88 children, with symptoms ranging from mild personality traits to severe intellectual disability and seizures. Understanding the altered genetic pathways is critical for diagnosis and treatment.
More than half of air travellers find that their oxygen saturation drops to a level at which many hospital patients would be prescribed extra oxygen, according to a paper in the May issue of Anaesthesia.
› Verified 8 days ago
David L. Rifken, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Locust St, Northampton, MA 01060 Phone: 413-582-2101 Fax: 413-582-2949 | |
Boris Nikolic, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Locust St, Northampton, MA 01060 Phone: 413-582-2554 Fax: 413-582-4779 | |
Andrew Michael Ciccarelli, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Locust St, Northampton, MA 01060 Phone: 413-582-2101 Fax: 413-582-2949 | |
Dr. John M Sheldon, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Cancer Center At Cooley Dickinson, 30 Locust Street, Northampton, MA 01060 Phone: 413-582-2107 Fax: 413-582-2963 | |
Timothy C. Tash, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Locust St, Northampton, MA 01060 Phone: 800-688-6663 Fax: 413-582-2949 | |
Joseph R. Polino Jr., MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 Locust St, Northampton, MA 01060 Phone: 413-582-2101 Fax: 413-582-2949 |